Objective: To evaluate the safety of an intra-articular injection of non-animal stabilised hyaluronic acid (NASHA ... physical and occupational therapy and drug therapy, are currently available.
Doron's most advanced product, MOTYS™, is an intra-articular biologic drug developed for the management of symptomatic knee osteoarthritis. Data from a Phase 2 clinical trial were recently presented ...